Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

5 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Alpha-fetoprotein response predicts treatment outcomes in patients with unresectable hepatocellular carcinoma receiving immune checkpoint inhibitors with or without tyrosine kinase inhibitors or locoregional therapies.
Hsu WF, Wang HW, Chen CK, Lai HC, Chuang PH, Tsai MH, Su WP, Chen HY, Chu CS, Chou JW, Chen SH, Tsai TY, Hsiao WD, Lin CC, Huang GT, Lin JT, Peng CY. Hsu WF, et al. Among authors: hsiao wd. Am J Cancer Res. 2021 Dec 15;11(12):6173-6187. eCollection 2021. Am J Cancer Res. 2021. PMID: 35018250 Free PMC article.
Declining trends of prevalence of Helicobacter pylori infection and incidence of gastric cancer in Taiwan: An updated cross-sectional survey and meta-analysis.
Chen MJ, Bair MJ, Chen PY, Lee JY, Yang TH, Fang YJ, Chen CC, Chang AT, Hsiao WD, Yu JJ, Kuo CC, Chiu MC, Lin KP, Tsai MH, Hsu YC, Chou CK, Chen CY, Lin JT, Lee YC, Wu MS, Liou JM; for the Taiwan Gastrointestinal Disease and Helicobacter Consortium. Chen MJ, et al. Among authors: hsiao wd. Helicobacter. 2022 Oct;27(5):e12914. doi: 10.1111/hel.12914. Epub 2022 Jul 18. Helicobacter. 2022. PMID: 35848363
Combined CRAFITY score and α-fetoprotein response predicts treatment outcomes in patients with unresectable hepatocellular carcinoma receiving anti-programmed death-1 blockade-based immunotherapy.
Hsu WF, Lai HC, Chen CK, Wang HW, Chuang PH, Tsai MH, Chen SH, Chu CS, Su WP, Chou JW, Kao JT, Chen HY, Chuang SC, Tsai TY, Hsiao WD, Huang GT, Peng CY. Hsu WF, et al. Among authors: hsiao wd. Am J Cancer Res. 2023 Feb 15;13(2):654-668. eCollection 2023. Am J Cancer Res. 2023. PMID: 36895987 Free PMC article.